Washington D.C. – The Food and Drug Administration (FDA) is facing mounting criticism following reports that it withheld the publication of several studies affirming the safety of COVID-19 and shingles vaccines. The decision to suppress these studies, which were conducted by FDA scientists using taxpayer funds, has fueled accusations of bureaucratic overreach and a potential disregard for scientific integrity.

According to a spokesperson for the Department of Health and Human Services (HHS), the FDA blocked the release of the studies based on concerns that the authors’ conclusions were not adequately supported by the underlying data. However, critics argue that the FDA’s actions represent an unwarranted intrusion into the scientific process and an attempt to control the narrative surrounding vaccine safety.

Andrew Nixon, an HHS spokesperson, defended the FDA’s actions, stating that the withdrawals were necessary to “protect the integrity of its scientific process and ensure that any work associated with the agency meets its high standards.” However, this explanation has failed to quell concerns among those who believe that the FDA should prioritize transparency and allow for open scientific debate.

One of the suppressed studies, first reported by the New York Times, examined the safety of COVID-19 vaccines in individuals over 65 by reviewing the medical records of approximately 7.5 million Medicare beneficiaries. The study reportedly found that anaphylaxis was the only significant concern, affecting approximately one in a million recipients of the Pfizer vaccine. Despite the reassuring findings, the study was ultimately withdrawn.

Another withdrawn study investigated COVID-19 vaccine safety in 4.2 million individuals between six months and 64 years old, identifying rare instances of fever-related seizures and myocarditis. While the study acknowledged that “Given the available evidence, FDA continues to conclude the benefits of vaccination outweigh the risks,” the decision to suppress its publication raises concerns about the agency's commitment to providing the public with complete and unbiased information.

Dorit Reiss, a law professor at UC Law San Francisco specializing in vaccine-related legal and policy matters, stated, “The fact that in one case these were accepted by a journal and that they are open about not liking the conclusion makes it more jarring,” highlighting the potential for political influence in scientific decision-making.